MA

Mark A. Demitrack

Neuronetics, Inc.

Affiliated withInc.

Research Area

Biography

Mark A. Demitrack has not added Biography.
If you are Mark A. Demitrack and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 83	2010

Other Publications

Article	Year
Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial. The Journal of clinical psychiatry\| PubMed ID: 11926722	2002
The tyramine pressor test may have limited sensitivity, especially in the presence of dual serotonin/norepinephrine uptake inhibition. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology\| PubMed ID: 11927196	2002
Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. The Journal of clinical psychiatry\| PubMed ID: 12000204	2002
Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression. Journal of psychiatric research\| PubMed ID: 12393307	2002
Effects of duloxetine on painful physical symptoms associated with depression. Psychosomatics\| PubMed ID: 14709757	2004
Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain, behavior, and immunity\| PubMed ID: 15157948	2004
Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine. Journal of clinical psychopharmacology\| PubMed ID: 15232330	2004
Can monoamine-based therapies be improved? The Journal of clinical psychiatry\| PubMed ID: 15453009	2002
Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology\| PubMed ID: 15589385	2004
Clinical methodology and its implications for the study of therapeutic interventions for chronic fatigue syndrome: a commentary. Pharmacogenomics\| PubMed ID: 16610962	2006
Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biological psychiatry\| PubMed ID: 17573044	2007
Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroductio... The Journal of clinical psychiatry\| PubMed ID: 18232722	2008
Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial. The Journal of clinical psychiatry\| PubMed ID: 18294022	2008
Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis. Advances in therapy\| PubMed ID: 19330495	2009
Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data. Psychopharmacology bulletin\| PubMed ID: 19629020	2009
Reply regarding "efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial". Biological psychiatry\| PubMed ID: 19914602	2010
Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-la... Brain stimulation\| PubMed ID: 20965447	2010

Copyright © 2026 MyJoVE Corporation. All rights reserved.